Oppenheimer & CO Inc Orchard Therapeutics PLC Transaction History

Oppenheimer & CO Inc

  • $6.42 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
SELL
$0.36 - $0.49 $72 - $98
-200 Reduced 1.71%
11,500 $4,000
Q3 2022

Nov 14, 2022
SELL
$0.45 - $0.69 $1,080 - $1,655
-2,400 Reduced 17.02%
11,700 $6,000
Q2 2022

Aug 08, 2022
BUY
$0.42 - $0.78 $1,050 - $1,950
2,500 Added 21.55%
14,100 $8,000
Q1 2022

May 12, 2022
BUY
$0.7 - $1.51 $8,119 - $17,516
11,600 New
11,600 $8,000

Others Institutions Holding ORTX

# of Institutions
4
Shares Held
545K
Call Options Held
0
Put Options Held
0
View Full List

About Orchard Therapeutics plc

ORTX Quotes by TradingView
  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email